Senate report: Avandia maker knew of cardiac risks
A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence
Last 5 posts in Health
- Are Migraines Linked to a Heart Defect? - July 29th, 2010
- Monitoring Mother - July 29th, 2010
- Hire scheme aims to get Londoners on bikes - July 29th, 2010
- The Cruelest Month: For Some Fitness Buffs, July Heat Is No Obstacle - July 29th, 2010
- Sanofi Said to Plan a Bid of $70 for Genzyme - July 29th, 2010